Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Université de Montpellier, CHU de Montpellier, France.
Inserm UMR 1141 - PROTECT, Hôpital Robert Debré, 48, Boulevard Sérurier, 75019, Paris, France.
Eur J Hum Genet. 2019 Nov;27(11):1692-1700. doi: 10.1038/s41431-019-0433-2. Epub 2019 Jul 8.
Early infantile epileptic encephalopathy (EIEE) is a heterogeneous group of severe forms of age-related developmental and epileptic encephalopathies with onset during the first weeks or months of life. The interictal electroencephalogram (EEG) shows a "suppression burst" (SB) pattern. The prognosis is usually poor and most children die within the first two years or survive with very severe intellectual disabilities. EIEE type 3 is caused by variants affecting function, in SLC25A22, which is also responsible for epilepsy of infancy with migrating focal seizures (EIMFS). We report a family with a less severe phenotype of EIEE type 3. We performed exome sequencing and identified two unreported variants in SLC25A22 in the compound heterozygous state: NM_024698.4: c.[813_814delTG];[818 G>A] (p.[Ala272Glnfs*144];[Arg273Lys]). Functional studies in cultured skin fibroblasts from a patient showed that glutamate oxidation was strongly defective, based on a literature review. We clustered the 18 published patients (including those from this family) into three groups according to the severity of the SLC25A22-related disorders. In an attempt to identify genotype-phenotype correlations, we compared the variants according to the location depending on the protein domains. We observed that patients with two variants located in helical transmembrane domains presented a severe phenotype, whereas patients with at least one variant outside helical transmembrane domains presented a milder phenotype. These data are suggestive of a continuum of disorders related to SLC25A22 that could be called SLC25A22-related disorders. This might be a first clue to enable geneticists to outline a prognosis based on genetic molecular data regarding the SLC25A22 gene.
早发性婴儿癫痫性脑病(EIEE)是一组异质性严重的与年龄相关的发育性和癫痫性脑病,发病于生命的最初几周或几个月。发作间期脑电图(EEG)显示“抑制爆发”(SB)模式。预后通常较差,大多数儿童在头两年内死亡,或存活下来但智力残疾非常严重。EIEE 型 3 是由影响功能的变异引起的,该变异影响 SLC25A22 中的功能,SLC25A22 也负责婴儿癫痫伴移行性局灶性发作(EIMFS)。我们报告了一个具有较轻 EIEE 型 3 表型的家族。我们进行了外显子组测序,在复合杂合状态下发现 SLC25A22 中两个未报道的变异:NM_024698.4:c.[813_814delTG];[818 G>A](p.[Ala272Glnfs*144];[Arg273Lys])。对患者培养的皮肤成纤维细胞进行的功能研究表明,根据文献综述,谷氨酸氧化严重缺陷。根据 SLC25A22 相关疾病的严重程度,我们将 18 名已发表的患者(包括该家族患者)分为三组。为了尝试确定基因型-表型相关性,我们根据位于蛋白结构域的位置比较了变异。我们观察到,具有两个位于螺旋跨膜结构域的变异的患者表现出严重的表型,而至少有一个位于螺旋跨膜结构域外的变异的患者表现出较轻的表型。这些数据提示 SLC25A22 相关疾病存在一个与 SLC25A22 相关的疾病连续体。这可能是遗传学家根据 SLC25A22 基因的遗传分子数据概述预后的第一个线索。